| For: | Mathonnet M, Descottes B, Valleix D, Labrousse F, Denizot Y. VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues. World J Gastroenterol 2006; 12(5): 830-831 [PMID: 16521208 DOI: 10.3748/wjg.v12.i5.830] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i5/830.htm |
| Number | Citing Articles |
| 1 |
Pradeep Madhamanchi, Kishore Madhamanchi, Sujatha Peela, Panchareddy Madhava Rao, Pallaval Veera Bramhachari, Prakash Babu Panithi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; doi: 10.1016/B978-0-323-98807-0.00021-1
|
| 2 |
De-cai Yu, Jun Chen, Xi-tai Sun, Lin-yuan Zhuang, Chun-ping Jiang, Yi-tao Ding. Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-435
|
| 3 |
De-Cai Yu, Jun Chen, Yi-Tao Ding. Hypoxic and Highly Angiogenic Non-Tumor Tissues Surrounding Hepatocellular Carcinoma: The ‘Niche’ of Endothelial Progenitor Cells. International Journal of Molecular Sciences 2010; 11(8) doi: 10.3390/ijms11082901
|
| 4 |
Mohamed Nasr, Ahmed Y. Kira, Sameh Saber, Ebtessam A. Essa, Sanaa A. El-Gizawy. Lactosylated Chitosan Nanoparticles Potentiate the Anticancer Effects of Telmisartan In Vitro and in a N-Nitrosodiethylamine-Induced Mice Model of Hepatocellular Carcinoma. Molecular Pharmaceutics 2023; 20(9) doi: 10.1021/acs.molpharmaceut.3c00542
|
| 5 |
Muttiah Barathan, Behnaz Riazalhosseini, Thevambiga Iyadorai, Kumutha Malar Vellasamy, Jamuna Vadivelu, Li-Yen Chang, Ahmad Khusairy Zulpa, Marie Larsson, Esaki M. Shankar, Rosmawati Mohamed. Comparative expression of pro-inflammatory and apoptotic biosignatures in chronic HBV-infected patients with and without liver cirrhosis. Microbial Pathogenesis 2021; 161 doi: 10.1016/j.micpath.2021.105231
|
| 6 |
Christopher L. Daige, Jason F. Wiggins, Leslie Priddy, Terri Nelligan-Davis, Jane Zhao, David Brown. Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer. Molecular Cancer Therapeutics 2014; 13(10) doi: 10.1158/1535-7163.MCT-14-0209
|
| 7 |
Josef Ehling, Frank Tacke. Role of chemokine pathways in hepatobiliary cancer. Cancer Letters 2016; 379(2) doi: 10.1016/j.canlet.2015.06.017
|
| 8 |
Zahra Farzaneh, Massoud Vosough, Tarun Agarwal, Maryam Farzaneh. Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01924-w
|
| 9 |
Yun-Qing Qiu, Jue Zhou, Xin-Shan Kang, Lie-Ming Ding, Wei Yu, Fen-Lai Tan, Dan-Feng Deng. Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model. Scientific Reports 2014; 4(1) doi: 10.1038/srep04324
|
| 10 |
Yasser Bakr Mohamed, Ula M. Al-Jarhi, Mona Mohsen, Sarah Ahmad El Morsy. Urinary Vascular Endothelial Growth Factor (VEGF) as a Novel Marker for Early Prediction of Esophageal Varices in Patients with Chronic Liver Disease. Open Journal of Gastroenterology 2017; 7(05) doi: 10.4236/ojgas.2017.75016
|
| 11 |
Stefano Ginanni Corradini, Sergio Morini, Francesca Liguori, Simone Carotti, Andrea Onetti Muda, Maria Antonella Burza, Maria Siciliano, Antonio Molinaro, Alfredo Cantafora, Ida Blotta, Manuela Merli, Pasquale Berloco, Massimo Rossi, Adolfo Francesco Attili, Eugenio Gaudio. Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and α‐fetoprotein. Liver International 2009; 29(1) doi: 10.1111/j.1478-3231.2008.01781.x
|
| 12 |
Andry Irawan, Erik Prabowo, Ignatius Riwanto, Wahyuni Lukita Atmodjo. Anti-angiogenic effect of the combination low-dose sorafenib and EGCG in HCC-induced Wistar rats. F1000Research 2022; 11 doi: 10.12688/f1000research.109142.1
|
| 13 |
Yves Denizot, Véronique Truffinet, François Labrousse, Denis Valleix, Bernard Descottes, Muriel Mathonnet. Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(23): 3782-3783 doi: 10.3748/wjg.v12.i23.3782
|
| 14 |
Ana Campillo, Estela Solanas, Maria J. Morandeira, Tomas Castiella, Sara Lorente, Francisco Agustín Garcia-Gil, Elena Piazuelo, Alba de Martino, Maria T. Serrano. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation. European Journal of Gastroenterology & Hepatology 2014; 26(8) doi: 10.1097/MEG.0000000000000131
|
| 15 |
Decai Yu, Linyuan Zhuang, Xitai Sun, Jun Chen, Yongzhong Yao, Kui Meng, Yitao Ding. Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma. BMC Cancer 2007; 7(1) doi: 10.1186/1471-2407-7-122
|
| 16 |
Stephen Fahey, Eugene Dempsey, Aideen Long. The role of chemokines in acute and chronic hepatitis C infection. Cellular & Molecular Immunology 2014; 11(1) doi: 10.1038/cmi.2013.37
|
| 17 |
Richard S. Finn, Yoon-Koo Kang, Mary Mulcahy, Blase N. Polite, Ho Yeong Lim, Ian Walters, Christine Baudelet, Demetrios Manekas, Joong-Won Park. Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research 2012; 18(7) doi: 10.1158/1078-0432.CCR-11-1991
|
| 18 |
Wagdy M. Eldehna, Ghada H Al-Ansary, Tarfah Al-Warhi, Maiy Y Jaballah, Mahmoud Elaasser, Mahmoud Rashed. Identification of novel ureido benzothiophenes as dual VEGFR-2/EGFR anticancer agents. Bioorganic Chemistry 2024; 143 doi: 10.1016/j.bioorg.2023.107037
|
| 19 |
Hidenori Shiraha, Shin‐ichi Nishina, Kazuhide Yamamoto. Loss of runt‐related transcription factor 3 causes development and progression of hepatocellular carcinoma. Journal of Cellular Biochemistry 2011; 112(3) doi: 10.1002/jcb.22973
|
| 20 |
Shakir Saleem, Imran Kazmi, Aftab Ahmad, Mohammed F. Abuzinadah, Ali Samkari, Huda M. Alkrathy, Ruqaiyah Khan. Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats. Nutrition and Cancer 2020; 72(1) doi: 10.1080/01635581.2019.1614199
|
| 21 |
Satoshi Kuboki, Hiroaki Shimizu, Noboru Mitsuhashi, Kimihiko Kusashio, Fumio Kimura, Hiroyuki Yoshidome, Masayuki Ohtsuka, Atsushi Kato, Hideyuki Yoshitomi, Masaru Miyazaki. Angiopoietin‐2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2008; 23(7pt2) doi: 10.1111/j.1440-1746.2007.05175.x
|
| 22 |
Osmar Damasceno Ribeiro, Nathalie Henriques Silva Canedo, Vera Lucia Pannain. Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features. Clinics 2016; 71(11) doi: 10.6061/clinics/2016(11)04
|
| 23 |
|
| 24 |
Andry Irawan, Erik Prabowo, Ignatius Riwanto, Wahyuni Lukita Atmodjo. Anti-angiogenic effect of the combination of low-dose sorafenib and EGCG in HCC-induced Wistar rats. F1000Research 2022; 11 doi: 10.12688/f1000research.109142.2
|
| 25 |
Ghada M. Salum, Noha G. Bader El Din, Marwa K. Ibrahim, Mohamed A. Anany, Reham M. Dawood, Ahmed Khairy, Mostafa K. El Awady. Vascular Endothelial Growth Factor Expression in Hepatitis C Virus-Induced Liver Fibrosis: A Potential Biomarker. Journal of Interferon & Cytokine Research 2017; 37(7) doi: 10.1089/jir.2016.0127
|
| 26 |
Andry Irawan, Erik Prabowo, Ignatius Riwanto, Wahyuni Lukita Atmodjo. Anti-angiogenic effect of the combination of low-dose sorafenib and EGCG in HCC-induced Wistar rats. F1000Research 2022; 11 doi: 10.12688/f1000research.109142.3
|